Aqilion is a Swedish biotechnology company established in 2002, specializing in the development of novel therapies targeting diseases driven by chronic inflammation and impaired immune responses. The company, based in Helsingborg and Gothenburg, focuses on life science, pharmaceuticals, and medical technology sectors, aiming to create innovative solutions to address unmet medical needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.